Measuring Plasma Orexin Concentrations in Narcolepsy and Idiopathic Hypersomnia
Not Applicable
- Conditions
- arcolepsy &idiopathic hypersomnia
- Registration Number
- JPRN-UMIN000015562
- Lead Sponsor
- Department of Laboratory Medicine, School of Medicine, Keio University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
The control group consists of normal subjects without sleep disorders, mental disorders, the direct physiological effects of a substance (e.g., a sedative, hypnotic, or stimulant, etc.), and severe physical diseases. Patients with anemia or renal failure are excluded from the narcolepsy group, the idiopathic hypersomnia group, and the control group.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method plasma orexin concentrations
- Secondary Outcome Measures
Name Time Method sleepiness measured with the Multiple Sleep Latency Test (MSLT) Epworth Sleepiness Scale (ESS) Visual Analog Scale (VAS)